Epsilogen
Description: Epsilogen develops IgE antibodies for potent, targeted cancer treatment with enhanced tumor access & long half-life.
Country: UK
Based in: London
Founded: 2016
Funding Stage: Series A/B
Tags: ['Biopharma', 'Biotechnology', 'Genetics', 'Life Science', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
